Fructose-1,6-diphosphate suppresses T-lymphocyte proliferation, promotes apoptosis and inhibits interleukins-1, 6, β-actin mRNAs, and transcription factors expression

Immunological Investigations

Volumn 33, Issue 4, 2004, Pages 407-421

  Cohly, H ^a   Jenkins, J ^a   Skelton, T ^a   Meydrech, E ^b   Markov, Angel K ^a  

^a UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

Author keywords

actin; 6 diphosphate; Fructose 1; Interleukins; T cells; Transcription factors

Indexed keywords

BETA ACTIN; CONCANAVALIN A; CYTOKINE; DNA FRAGMENT; FRUCTOSE 1 PHOSPHATE; FRUCTOSE 1,6 BISPHOSPHATE; FRUCTOSE 6 PHOSPHATE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1; INTERLEUKIN 6; MANNOSE 6 PHOSPHATE; MESSENGER RNA; PROPIDIUM IODIDE; THYMIDINE; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR AP 1;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; CYTOSKELETON; FLOW CYTOMETRY; GEL MOBILITY SHIFT ASSAY; GENE EXPRESSION; IMMUNOCOMPETENT CELL; INCUBATION TIME; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPLEEN CELL; T LYMPHOCYTE;

ACTINS; ANIMALS; APOPTOSIS; CELL PROLIFERATION; CELLS, CULTURED; ELECTROPHORETIC MOBILITY SHIFT ASSAY; FRUCTOSEDIPHOSPHATES; GENE EXPRESSION REGULATION; INTERLEUKIN-1; INTERLEUKIN-6; NF-KAPPA B; RATS; RNA, MESSENGER; SPLEEN; T-LYMPHOCYTES; TRANSCRIPTION FACTOR AP-1; TRANSCRIPTION FACTORS;

EID: 9744235059     PISSN: 08820139     EISSN: None     Source Type: Journal    
DOI: 10.1081/IMM-200038668     Document Type: Article

References (39)

1. Abmayr, S., Workman, J. L. (1997). DNA protein interactions. In: Ausubel, F. M., Brent, R., Kingston, R. E., Moore, D. O., Seidman, J. G., Smith, J. A., Struhl, K., Albright, L. M., Coen, O. M., Vark, A., eds. Protocols in Molecular Biology. New York: John Wiley & Sons, p. 12.1.
2. Bonz, A. W., Lengenfelder, B., Jacobs, M., Strotmann, J., Held, S., Ertl, G., Voelker, W. (2003). Cytokine response after percutaneous coronary intervention in stable angina: effect of selective glycoprotein IIb/IIIa receptor antagonism. Am. Heart J. 145:693-699.
3. Bradford, M. M. (1976). A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:248-254.
4. Breuss, J. M., Cejna, M., Bergmeister, H., Kadl, A., Baumgartl, G., Steurer, S., Xu, Z., Koshelnick, Y., Lipp, J., De Martin, R., Losert, U., Lammer, J., Binder, B. R. (2002). Activation of nuclear factor-kappa B significantly contributes to lumen loss in a rabbit iliac artery balloon angioplasty model. Circulation 105:633-638.
5. Cohly, H. H., Stephens, J. W., Angel, M. F., Johnson, J. C., Markov, A. K. (1999a). The role of fructose 1,6-diphosphate in cell migration and proliferation in an in vitro xenograft model of vascular wound healing. In Vitro Cell Dev. Biol. 35:510-514.
6. Cohly, H. H. P., Stephens, J. W., Angel, M. F., Johnson, J., Markov, A. K. (1999b). Role of fructose-1,6-diphosphate in cell migration and proliferation in an in vitro xenograft blood vessel model of vascular wound healing. In Vitro Cell Dev. BioAnim. 35:510-514.
7. Cohly, H., Stephens, J., Markov, A., Angel, M., Campbell, W., Ndebele, K., Jenkins, J. (2001). Cell culture conditions affect LPS inducibility of the inflammatory mediators in J774A.1 murine macrophages. Immunol. Invest. 30:1-15.
8. Danenberg, H. D., Welt, F. G., Walker, M. III, Seifert, P., Toegel, G. S., Edelman, E. R. (2002). Systemic inflammation induced by lipopolysaccharide increases neointimal formation after balloon and stent injury in rabbits. Circulation 105:2917-2922.
9. Dignam, J. D., Lebovitz, R. M., Roeder, R. G. (1983). Accurate transcription by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res. 11:1475-1489.
10. Farias, L. A., Smith, E. E., Markov, A. K. (1990). Prevention of ischemic-hypoxic brain injury and death in rabbits with fructose-1,6- diphosphate. Stroke 21:606-613.
11. Fultz, M. E., Wright, G. L. (2003). Myosin remodeling in the contracting A7r5 smooth muscle cell. Acta Physiol Scand. 177:197-205.
12. Hardin, C. D., Roberts, T. M. (1994). Metabolism of exogenously applied fructose 1,6-bisphosphate in hypoxic vascular smooth muscle. Am. J. Physiol 267:H2325-H2332.
13. Hassinen, I. E., Nuutinen, E. M., Ito, K., Nioka, S., Lazzarino, G., Giardina, B., Chance, B. (1991). Mechanism of the effect of exogenous fructose-1,6-bisphosphate on myocardial energy metabolism. Circulation 83:584-593.
14. Hojo, Y., Ikeda, U., Katsuki, T., Mizuno, O., Fukazawa, H., Kurosaki, K., Fujikawa, H., Shimada, K. (2000). Interleukin expression in coronary circulation after coronary angioplasty as a risk factor for restenosis. Heart 84:83-87.
15. Jenkins, J. K., Suwannaroj, S., Elbourne, K. B., Ndebele, K., McMurray, R. W. (2001). 17-β estradiol alters Jurkat lymphocyte cell cycling and induces apoptosis through suppression of bcl-2 and cyclin A. Int. Immunopharmacol. 1:1867-1911.
16. Johnson, D. E., Gao, S. Z., Schroeder, J. S., DeCampli, W. M., Billingham, M. E. (1989). The spectrum of coronary artery pathologic findings in human cardiac allografts. J. Heart Transplant. 8:349-359.
17. Kermode, H., Chan, W. M., Williams, A. J., Sitsapesan, R. (1998). Glycolytic pathway intermediates activate cardiac ryanodine receptors. FEBS Lett. 431:59-62.
18. Kirtley, M. E., McKay, M. (1977). Fructose-1,6-diphosphate, a regulator of metabolism. Mol. Cell. Biochem. 18:141-149.
19. Marangos, P. J., Fox, A. W., Rriedel, B. J., Royston, D., Dziewanowska, Z. E. (1998). Potential therapeutic applications of fructose-1,6-diphosphate. Exp. Opin. Invest. Drugs 7:615-623.
20. Marchionni, N., Conti, A., De Alfieri, W., Di Bari, M., Ferrucci, L., Lombardi, A., Moschi, G., Pini, R., Vannucci, A. (1985). Hemodynamic and electrocardiographic effects of fructose-1,6-diphosphate in acute myocardial infarction. Am. J. Cardiol. 56:266-269.
21. Markov, A. K. (1986). Hemodynamic and metabolic effects of fructose-1,6-diphosphate in ischemia and shock. Experimental and clinical observations. Ann. Emerg. Med. 15:1470-1477.
22. Markov, A. K., Oglethorpe, N. C., Blake, T. M., Lehan, P. H., Hellems, H. K. (1980). Hemodynamic, electrocardiographic, and metabolic effects of fructose diphosphate on acute myocardial ischemia. Am. Heart J. 100:639-646.
23. Markov, A. K., Neely, W. A., Didlake, R. H., Terry, J. III, Causey, A., Lehan, P. H. (2000). Metabolic responses to fructose-1,6-diphosphate in healthy subjects. Metabolism 49:698-703.
24. Markov, A. K., Rayburn, T. S., Talton, D. S., Netherland, D. E., Moore, C., Heath, B., Cohly, H. H. (2002a). Fructose-1,6-diphosphate alone and in combination with cyclosporine potentiates rat cardiac allograft survival and inhibits lymphocyte proliferation and interleukin-2 expression. Transplantation 74:1651-1654.
25. Markov, A. K., Causey, A. L., Didlake, R. H., Lemos, L. B. (2002b). Prevention of alphanaphthylthiourea-induced pulmonary edema with fructose-1,6-diphosphate. Exp. Lung Res. 28:285-299.
26. McMurray, R. W., Ndebele, K., Hardy, K. J., Jenkins, J. K. (2001). 17-∃ estradiol suppresses IL-2 and IL-2 receptor. Cytokine 14:324-333.
27. Nicoletti, I., Migliorati, G., Pagliacci, M. C., Grignani, F., Riccardi, C. (1991). A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J. Immunol. Methods 139:271-279.
28. North, A. J., Gimona, M., Lando, Z., Small, J. V. (1994). Actin isoform compartments in chicken gizzard smooth muscle cells. J. Cell Sci. 107:445-455.
29. Paul, L. C., Fellstrom, B. (1992). Chronic vascular rejection of the heart and the kidney, have rational treatment options emerged? Transplantation 53:1169-1179.
30. Rus, H. G., Vlaicu, R., Niculescu, F. (1996). Interleukin-6 and interleukin-8 protein and gene expression in human arterial atherosclerotic wall. Atherosclerosis 127:227-263.
31. Russell, M. E., Fujita, M., Masek, M. A., Rowan, R. A., Billingham, M. E. (1993). Cardiac graft vascular disease. Nonselective involvement of large and small vessels. Transplantation 56:1599-1601.
32. Schedlich, L., Hill, M., Lockert, T. (1997). Antisense inhibition of beta-actin mRNA localization and its effect on smooth muscle cell migration. Biol. Cell 89:113-122.
33. Schevzov, G., Lloyd, C., Gunning, P. J. (1992). High level expression of transfected beta-and gamma-actin genes differentially impacts on myoblast cytoarchitecture. Cell Biol. 117:775-785.
34. Schulte, H. M., Bamberger, C. M., Elsen, H., Herrmann, G., Bamberger, A. M., Barth, J. (1994). Systemic interleukin-1 alpha and interleukin-2 secretion in response to acute stress and to corticotropin-releasing hormone in humans. Eur. J. Clin. Invest. 24:773-777.
35. Steel, R. G. D., Torrie, J. H. (1960). Analysis of variance 1: the one way classification. In: Steel, R. G. D., Torrie, J. H., eds. Principles and Procedures of Statistics. New York: McGraw-Hill Book Company, pp. 111-112.
36. Sun, J. X., Farias, L. A., Markov, A. K. (1990). Fructose-1,6-diphosphate prevents intestinal ischemic reperfusion injury and death in rats. Gastroenterology 98:117-126.
37. Tamaki, T., Nakai, T., Yamaue, H. (2002). Fructose-1,6-biphosphate inhibits excess activation of Kupffer cell function induced by endotoxin. Dig. Dis. Sci. 47:2179-2185.
38. Tullius, S., Tilney, N. L. (1995). Both alloantigen-dependent and independent factors influence chronic rejection. Transplantation 59:313-318.
39. Yamasaki, K., Asai, T., Shimizu, M., Aoki, M., Hashiya, N., Sakonjo, H., Makino, H., Kaneda, Y., Ogihara, T., Morishita, R. (2003). Inhibition of NF-kappa B activation using cis-element 'decoy' of NF-kappa B binding site reduces neointimal formation in porcine balloon-injured coronary artery model. Gen. Ther. 10:356-364.